Navigation Links
Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
Date:1/15/2008

Presentations to Detail Latest Cardiac Surgery Technology to be Held

January 26th at 6:30 p.m. Eastern Time

FORT LAUDERDALE, Fla., Jan. 15 /PRNewswire-FirstCall/ -- Five leading medical technology companies will host the first annual After Hours Event on January 26, 2008 at 6:30 p.m. in Fort Lauderdale, aboard the yacht "Princess Lady." The invitation-only event, immediately preceding the largest meeting of cardiothoracic surgeons in North America, will feature comprehensive presentations and open discussions by renowned cardiac and thoracic surgeons highlighting the latest medical therapies and technologies.

Presentations scheduled for the event include:

Autofluorescence Brochoscopy and Photodynamic Therapy: A Thoracic Surgeon's Perspective by Patrick Ross Jr., M.D., Ph.D., associate professor and director of general surgery at the Arthur G. James Cancer Hospital and Solove Research Institute in Columbus, Ohio;

Why Go On Pump?: A Clinical and Economic Perspective of Why Our Practice Converted to OPCAB with the C-Port xA(R) Distal Anastomosis System by Nicholas V. Augelli, M.D., cardiothoracic surgeon for the Genesis Heart Institute in Davenport, Iowa;

Closed-Chest, Beating Heart Cardiac Ablation with the SOLAR(TM) System by Husam Balkhy, M.D., chairman of the department of cardiothoracic surgery for The Wisconsin Heart Hospital in Wauwatosa, Wis.;

SPY Intra-Operative Imaging in Graft Assessment by David Paul Taggart, M.D., Ph.D., FRCS, professor of cardiovascular surgery for the John Radcliffe Hospital in Oxford, UK; and

Intra-Operative Assessment of Flow Measurement through a Limited Thoracotomy in Robotic Surgery by Francis Sutter, D.O., FACS, clinical professor of surgery for Jefferson Medical College and cardiothoracic surgeon for Lankenau Hospital in Philadelphia, Pa.

The event is sponsored by Axcan Pharma (Nasdaq:

SOURCE Axcan Pharma; Cardica, Inc.; MedicalCV, Inc.; NovadaqTechnologies;
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...re-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN )...onsbytheU.S.BankruptcyCourtfortheDistrictofDelawar...tarypetitionfor,reliefunderChapter11oftheUnitedSta...heordersissuedbytheBankruptcyCourtallowthecompanyt...oceedings.Inparticular,the,companyreceivedinterimB...
(Date:11/24/2009)...proved the Promega PowerPlex 16 HS System for use ... records for the National DNA Index System. , ...e FBI recently approved the Promega PowerPlex®...ing in, or generating DNA records for, the Nationa... more than seven million profiles and has assisted...
(Date:11/24/2009)...FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )today...airman,willpresentatthe21stAnnualPiperJaffrayHealt...09at10:00a.m.ET. ,, Toaccesstheliveandsubsequen...orRelationssectionofGenomicHealth,swebsiteat http:...bsiteatleast15minutespriortothebeginningoftheprese...
(Date:11/23/2009)...ative new study, a University of Utah scientist ar...or cause of global warming cannot be stabilized u...lds the equivalent of one new nuclear power plant ...be any substantial near-term departure from recent...n rates," says the new paper by Tim Garrett, an as...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
.... 28 Beckman,Coulter, Inc. (NYSE: BEC ), announc...ents with Adventist Health to provide a broad rang...t approximately $36 million over,six years. Advent... care,system with facilities in California, Hawaii...scom.com/cgi-bin/prnh/20031202/BECLOGO ), Under t...
...um Drives 71% Year-Over-Year Growth in Core ... Calif., Oct. 28 Cepheid (Nasdaq:,CPHD) today rep....9,million, an increase of 24% over the third quar...$(0.11) per share, which compares to revenue of $3....09) per share, in the third,quarter of fiscal 200...
...ovavax, Inc.,(Nasdaq: NVAX ) a clinical-stage vac...vi, President and Chief Executive Officer, will be... am. (PT) on October 30, 2008 at the,Palace Hotel ...vide an,overview of the company,s strategy, resear...esentation can be accessed via the Company website...
Other Biology Technology:Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care 2Cepheid Reports Third Quarter Revenue of $44.9 Million 2Cepheid Reports Third Quarter Revenue of $44.9 Million 3Cepheid Reports Third Quarter Revenue of $44.9 Million 4Cepheid Reports Third Quarter Revenue of $44.9 Million 5Cepheid Reports Third Quarter Revenue of $44.9 Million 6Cepheid Reports Third Quarter Revenue of $44.9 Million 7Cepheid Reports Third Quarter Revenue of $44.9 Million 8Cepheid Reports Third Quarter Revenue of $44.9 Million 9Cepheid Reports Third Quarter Revenue of $44.9 Million 10Cepheid Reports Third Quarter Revenue of $44.9 Million 11Cepheid Reports Third Quarter Revenue of $44.9 Million 12Cepheid Reports Third Quarter Revenue of $44.9 Million 13
(Date:11/24/2009)...of debate. A high-profile study a few years ago su...arbon from trees and leaves, evidence for a very c...ystems. , But new research from the University o...Algae provide a much richer diet for fish and othe...is week in the Proceedings of the National Academ...
(Date:11/23/2009)...vidence that the "synergistic" effect of early-lif...on and indoor endotoxin causes more harm to develo... , Environmental health scientists at the Univer...hown that children exposed to both high levels of ...ing early life are six times more likely to experi...
(Date:11/23/2009)...of day matters to forest trees dealing with drough... team led by Professor Malcolm Campbell, Universit...arch and colleagues in the department of cell and ...pitalizing on their previous work to decode the ge...d how poplar trees use their 45,000 genes to respo...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 1Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 1Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 3ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 1ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 2ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 3
...ist has discovered key appetite control cells in t...ased hunger and potentially weight-gain as we grow...oendocrinologist with Monash University,s Departme..., Dr Andrews found that appetite-suppressing cell...aid the degeneration is more significant following...
... many men during their fight against prostate canc...searchers have found. The findings were published ...edings of the National Academy of Sciences . , Th...edeviled patients for decades. Hormone therapy, a ...ncer, generally keeps the cancer at bay for a year...
...s(TM) Wireless Data Communications Link School ..., WALL, N.J., Aug. 20 BIO-key International,Inc....sed biometric,identification and wireless public s...of MobileSRO(TM) and MobileCampus(TM), silent, sec...-12 schools and higher,education, respectively., ...
Other Biology News:Killer carbs -- Monash scientist finds the key to overeating as we age 2Why a common treatment for prostate cancer ultimately fails 2Why a common treatment for prostate cancer ultimately fails 3Why a common treatment for prostate cancer ultimately fails 4BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3
Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-SOX10 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-Human GMNN Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Normal Human Serum from 3H Biomedical AB
Biology Products: